Trends, Industry Insights & Market Dynamics

Week Two - 4th - 8th October

Conference Content

Our Digital Content Programme brings you market trends, industry insights and innovative products and solutions - all delivered by thought leaders in the packaging and drug delivery space.

This year, the popular Pharmapack Conference is moving online. We will continue to host three tracks, Large Volume Drug Delivery, Sustainable Packaging, & Digital Health.

9:30-10:00

Welcome from Digital Health & Connectivity Sponsor Nemera

Séverine Duband, Marketing Director for drug delivery Devices, Nemera

10:00- 10:30

Keynote: Digital Health Regulatory Update - EMA & FDA Perspectives

Fabien Roy, Partner, Hogan Lovells International LLP

Jodi Scott, Partner, Hogan Lovells International LLP

10:30-11:00

Keynote: The True Track & Trace Value Proposition

Christophe Bureau, President, Beeyond

12:30-13:30

Industry Case Studies

12:30-12:50: Connected Electronic Injectors at Merck - Insights after more than 10 years of use

Quentin Le Masne, Director - Head of Business Development and Innovation, Connected Health & Devices, Merck KGaA

12:50-13:10: A first experience with the ava® electromechanical injector and its approach to connected health

Serkan Oray, Vice President, Devices, Packaging & Wearable Technologies, UCB

13:10-13:30: Designing patient-centred pharmaceutical packaging: Key insights from an industry-based research study.

Giana Carli Lorenzini, PhD, Postdoctoral research fellow, Lund University

14:00 - 15:00

Innovation in Connectivity Roundtable

Series of 20-minute presentations followed by a group discussion.

Patient Journey Driven Considerations for Integrating Digital Health for Combination Products.

Mark Tunkel, Global Category Director for Insight Innovation, Nemera

Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired

Laurent Tonnelier, CEO, mobiLead - xTag

Lise Wagner, Accessibility Specialist and User Expert, OKEENEA

Traceability of medicines: from finished product to unit dose delivery

Nathalie Wardé, CEO & Founder, D4P pharma

15:15-16:00 Innovation in Connectivity: Live Discussion & Q&A

Moderated by Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG

Participants:

Mark Tunkel, Global Category Director for Insight Innovation, Nemera
Laurent Tonnelier, CEO, mobiLead – xTag
Lise Wagner, Accessibility Specialist and User Expert, OKEENEA
Nathalie Wardé, CEO & Founder, D4P pharma

CUSTOM WEBINARS

4th October

11:00

Addressing the Evolving Needs of Complex or Variable Drug Delivery Regimens

The need to reduce health care costs, improve outcomes, and increase access to remote care are intensifying the focus on patient care delivery in the home setting. As a result, pharma is seeking alternate delivery systems that can provide patient autonomy and mobility while delivering treatment outside of the clinic. Programmable, variable dose on-body injectors provide such options. This talk will highlight considerations for on-body injectors to promote drug delivery in non-clinical settings.

Sylvine Raverdy-Wilson, BD

16:00

Combination Product Development Considerations for Subcutaneous 2 mL Dose Delivery

High dose biologic formulations are pushing drug volume and viscosity beyond traditional self-injection design space limits (> 15 cP, > 1 ml dose volume), which can challenge patients’ capabilities to administer their injections based on injection time or force.12 We will discuss how ergonomic, manual, syringe-based injections can enable subcutaneous self-injections with characteristics that go beyond the traditional boundaries of volume and viscosity. Important factors for development of combination products involving delivery of higher volumes (1-2 mL) are presented, including assembly, human factors, documentation, and platform considerations.

Karima Yadi, Senior Marketing Manager, BD

DIGITAL HEALTH & CONNECTIVITY

5th October

LARGE VOLUME DRUG DELIVERY

7th October

9:30-10:15	Welcome from Track Sponsor Interrogating Large Volume Subcutaneous Injection Using Translational Preclinical and Clinical Models and the Case Study “Clinical Evaluation of an Investigational 5 mL Wearable Injector Wendy Woodley, Staff Scientist, Translational & Clinical Sciences Center of Excellence, BD Technologies and Innovation. Natasha Bolick, Associate Director of Biomedical Engineering at the Parenteral Sciences Center of Excellence, BD Technologies and Innovation
10:30- 11:00	Innovation in Injectables and Devices Yasemin Karanis, Consultant, Thought Leadership, IQVIA
11:00- 11:30	BEPO® - an Innovative and Mature Long-Acting Injectable Technology Suitable for Low and Middle Income Countries Christophe Roberge, Senior Technology Advisor, MedinCell
11:30-12:00	Current Trends in Biosimilars and Impacts on Autoinjector Development Charbel Tengroth, Managing Director, Tengroth Consulting
13:00-13:30	Responding to the Vaccine Delivery Challenge Marie-Liesse Le Corfec, Global Portfolio Marketing Head, BD Guillaume Lehée, Innovation Leader, BD

SUSTAINABLE PACKAGING & DEVICES

6th October

9:30-10:00	Welcome from Track Sponsor: Covestro Sustainability Solutions for the Healthcare Market Irving Paz Chagoya, Healthcare Segment Manager EMEA, Covestro
10:00-10:30	Trends in Sustainable Packaging Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG
10:30-11:15	Defining Your Own Approach to Sustainability Tom Polton, Principal, NV Sustainability LCC Repurposed from CPhI North America
11:15-11:45	Practical Measures for Improving Sustainability and Reducing the Carbon Footprint of Medical Devices Brennan Miles, Team Consulting, Head of Drug Delivery, Team Consulting
11:45 - 12:15	Makrolon Polycarbonate Drug Delivery Device to Address Circularity Isaac Platte, Application Development Engineer, COVESTRO
14:00- 16:00	Sustainability in Packaging Roundtable Series of 20-minute presentations, followed by group discussion. Moderated by Yasemin Karanis, Consultant, Thought Leadership, IQVIA Better understand the challenges of eco-design for pharmaceutical packaging Romane Osadnick, Key Account Manager, Adelphe Circular Economy in Medical Devices, the use of Biosource and Recycled Materials Jean-Jacques LEGAT, Projects and Innovation Director, Polymeris Advanced Recycling of Healthcare Plastics: An Opportunity for Circularity Steven Meun, Director HPRC Europe, Healthcare Plastics Recycling Council Andrew W. Green, Market Development Manager, Rigid Medical Packaging Nick Packet, MDM Specialist - Packaging Engineer, DuPont Safety 15:15 -16:00 Live Discussion & Q&A Moderated by Yasemin Karanis, Consultant, Thought Leadership, IQVIA Participants: Romane Osadnick, Key Account Manager, Adelphe Jean-Jacques LEGAT, Projects and Innovation Director, Polymeris Steven Meun, Executive Director, HPRC Andrew W. Green, Market Development Manager, Rigid Medical Packaging

6th October

PODCAST

Integrating Bio-based and Recyclable Materials

The pharmaceutical packaging and drug delivery industries are coming under ever increasing scrutiny when it comes to making their packaging production processes sustainable.

Bio-based and recyclable plastic materials offer tremendous opportunities for packaging and devices companies, although their use has to be balanced against regulatory requirements as well as the needs of original equipment manufacturers.
In this interview with Jean-Jacques Legat, Projects and Innovation Director, Polymeris, and Manon Guyader, Innovation Health Project Manager, Polymeris, we discuss the various initiatives the business cluster is launching to address these vital issues.

Jean-Jacques LEGAT, Projects and Innovation Director, Polymeris

Manon Guyader, Innovation Manager, Polymeris